EC Nutrition

Novel medicine delivery and targeting for plant active compounds and extracts are the subjects of substantial ongoing study. Though, research in this area is still at the investigative stage. Many problems in the research, production and application need to be solved. Besides, more attention should be paid to the research on the carrier materials in view of developing more appropriate carriers which can reduce the toxicity of drugs, augment their activity and improve the overall quality of the agents. The enormous therapeutic potential of herbal medications should be investigated using value-added drug delivery methods. Standardized plant extracts or polar phytoconstituents including flavonoids, terpenoids, tannins, and xanthones have a significantly better absorption profile that enables them to pass through the biological barrier and boost bioavailability when administered through a novel drug delivery system. Because of this, a higher amount of the active ingredient is present at the site of action (liver, brain, heart, kidney, etc.) at a similar or lower dosage than with a conventional plant extract or phytomolecule. The outcome is a stronger, more noticeable, and longer-lasting therapeutic effect.

 Keywords: Drug Delivery System; Nanopharmaceuticals; Nanotechnology; Phytomolecule

1. Bhadoriya SS., et al. “Bioavailability and bioactivity enhancement of herbal drugs by Nanotechnology: a review”. Journal of Current Pharmaceutical Research1 (2011): 1-7.
2. Adhikari U., et al. “Nano particles of herbal origin: A recent eco-friend trend in mosquito control”. Asian Pacific Journal of Tropical Disease 2 (2013): 167-168.
3. Bayda S., et al. “The history of nanoscience and nanotechnology: From chemical-physical applications to nanomedicine”. Molecules1 (2019): 112.
4. Gnana Jobitha GD., et al. “Green synthesis of silver nanoparticle using Elettaria cardamomum and assessment of its antimicrobial activity”. International Journal of Pharma Sciences and Research3 (2012): 323-330.
5. Ansari SH., et al. “Influence of nanotechnology on herbal drugs: a review”. Journal of Advanced Pharmaceutical Technology and Research3 (2012): 142-146.
6. Pathak Y and Thassu D. “Drug delivery nanoparticles formulation and characterization”. Informa Healthcare, New York, USA; London, UK, 191 (2009): 3.
7. Yadav D., et al. “Novel approach: Herbal remedies and natural products in pharmaceutical science as nano drug delivery systems”. International Journal of Pharmacy and Technology3 (2011): 3092-3116.
8. Sun M.‌, et al. “Advances in nanotechnology-based delivery systems for curcumin”. Nanomedicine7 (2012): 1085-1100.
9. Kaur K., et al. “A review of recent curcumin analogues and their antioxidant, anti-inflammatory, and anticancer activities”. Antioxidants (Basel)9 (2024): 1092.
10. Kakkar V., et al. “Exploring solid lipid nanoparticles to enhance the oral bioavailability of curcumin”. Molecular Nutrition and Food Research 3 (2011): 495-503.
11. Anitha A., et al. “Preparation, characterization, in vitro drug release and biological studies of curcumin loaded dextran sulphate-chitosan nanoparticles”. Carbohydrate Polymers3 (2011): 1158-1164.
12. Wahid F., et al. “Nanocomposite hydrogels as multifunctional systems for biomedical applications: Current state and perspectives”. Composites Part B: Engineering 200 (2020): 108208.
13. Su X., et al. “Preparation and physiochemical properties of curcumin-loaded lipid cubic liquid crystalline nanoparticles”. Zhong Yao Cai2 (2012): 296-299.
14. Butte K., et al. “Optimisation and in vivo evaluation of pectin-based drug delivery system containing curcumin for colon”. International Journal of Biomaterials (2014): 924278.
15. Thamke NK. “Self-micro emulsifying drug delivery system (SMEDDS): A review”. World Journal of Pharmacy and Pharmaceutical Sciences (2017): 261-278.
16. Yang X., et al. “Curcumin-encapsulated polymeric micelles suppress the development of colon cancer in vitro and in vivo”. Scientific Reports1 (2015): 10322.
17. Gou M., et al. “Curcumin-loaded biodegradable polymeric micelles for colon cancer therapy in vitro and in vivo”. Nanoscale4 (2011): 1558-1567.
18. Tomeh MA., et al. “A review of curcumin and its derivatives as anticancer agents”. International Journal of Molecular Sciences5 (2019): 1033.
19. Dhule SS., et al. “Curcumin-loaded γ-cyclodextrin liposomal nanoparticles as delivery vehicles for osteosarcoma”. Nanomedicine: Nanotechnology, Biology, and Medicine4 (2012): 440-451.
20. Appendino G., et al. “Potential role of curcumin phytosome (Meriva) in controlling the evolution of diabetic microangiopathy: A pilot study”. Panminerva Medica 1 (2011): 43-49.
21. Peng Y., et al. “Anti-inflammatory effects of curcumin in the inflammatory diseases: Status, limitations and countermeasures”. Drug Design, Development and Therapy 15 (2021): 4503-4525.
22. Zhang H., et al. “Preparation and in vitro release characteristics of curcumin in nanosuspensions”. Zhongguo Zhong Yao Za Zhi2 (2011): 132-135.
23. Wang X., et al. “Preparation and optimization formulation of zedoary turmeric oil nanoemulsion based thermo-sensitive gel for improved application in ophthalmology”. Journal of Drug Delivery Science and Technology 65 (2021): 102682.
24. You J., et al. “Study of the preparation of sustained release microspheres containing zedoary turmeric oil by the emulsion solvent diffusion method and evaluation of the self-emulsification and bioavailability of the oil”. Colloids and Surfaces B: Biointerfaces 1 (2006): 35-41.
25. Lertsutthiwong P and Rojsitthisak P. “Chitosan-alginate nanocapsules for encapsulation of turmeric oil”. Pharmazie12 (2011): 911-915.